78 related articles for article (PubMed ID: 25575050)
1. [Inhibition of sunitinib on the expressions of PD-L1 and PD-L2 of mouse bone marrow-derived dendritic cells].
Zhao F; Mai H; Dong J; Li X; Tang Y; Chen L; Zhang B
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jan; 31(1):10-3. PubMed ID: 25575050
[TBL] [Abstract][Full Text] [Related]
2. [Sunitinib inhibits the expressions of co-stimulatory molecule ligands on dendritic cells].
Ding C; Mai H; Chen L; Zhang B
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Apr; 32(4):437-41. PubMed ID: 27053605
[TBL] [Abstract][Full Text] [Related]
3. Autocrine activation of canonical BMP signaling regulates PD-L1 and PD-L2 expression in human dendritic cells.
Martínez VG; Hidalgo L; Valencia J; Hernández-López C; Entrena A; del Amo BG; Zapata AG; Vicente A; Sacedón R; Varas A
Eur J Immunol; 2014 Apr; 44(4):1031-8. PubMed ID: 24532425
[TBL] [Abstract][Full Text] [Related]
4. [PD-L1/PD-L2 on human placenta-derived mesenchymal stem cells inhibits the IL-17 secretion of peripheral blood T cells].
Wang G; Wang F; Li H; Zhang L; Luan X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb; 29(2):132-6. PubMed ID: 23388330
[TBL] [Abstract][Full Text] [Related]
5. Expression of programmed-death receptor ligands 1 and 2 may contribute to the poor stimulatory potential of murine immature dendritic cells.
Chen C; Qu QX; Huang JA; Zhu YB; Ge Y; Wang Q; Zhang XG
Immunobiology; 2007; 212(3):159-65. PubMed ID: 17412283
[TBL] [Abstract][Full Text] [Related]
6. Changes in the PD-1 and PD-L1 expressions of splenic dendritic cells in multiple-organ dysfunction syndrome mice and their significance.
Liu Q; Lu JY; Wang XH; Qu BJ; Li SR; Kang JR
Genet Mol Res; 2014 Sep; 13(3):7666-72. PubMed ID: 25299080
[TBL] [Abstract][Full Text] [Related]
7. Dendritic and stromal cells from the spleen of lupic mice present phenotypic and functional abnormalities.
Gleisner MA; Reyes P; Alfaro J; Solanes P; Simon V; Crisostomo N; Sauma D; Rosemblatt M; Bono MR
Mol Immunol; 2013 Jul; 54(3-4):423-34. PubMed ID: 23428837
[TBL] [Abstract][Full Text] [Related]
8. PD-1, PD-L1 and PD-L2 Gene Expression on T-Cells and Natural Killer Cells Declines in Conjunction with a Reduction in PD-1 Protein during the Intensive Phase of Tuberculosis Treatment.
Hassan SS; Akram M; King EC; Dockrell HM; Cliff JM
PLoS One; 2015; 10(9):e0137646. PubMed ID: 26359860
[TBL] [Abstract][Full Text] [Related]
9. [Bioimmunological characteristics of mature or immature murine dendritic cells].
Wang KL; Guo L; Shi RF; Wang JL; Dong SH
Zhonghua Yi Xue Za Zhi; 2011 Dec; 91(45):3225-8. PubMed ID: 22333110
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of programmed death ligand 1 in dendritic cells inhibits allogeneic lymphocyte activation in mice.
Li W; Wang X; Chen R; Zhu H; Chen G; Sun X
J Surg Res; 2012 Aug; 176(2):e79-87. PubMed ID: 22381170
[TBL] [Abstract][Full Text] [Related]
11. Fine-tuned expression of programmed death 1 ligands in mature dendritic cells stimulated by CD40 ligand is critical for the induction of an efficient tumor specific immune response.
Gu T; Zhu YB; Chen C; Li M; Chen YJ; Yu GH; Ge Y; Zhou SY; Zhou H; Huang Y; Qiu YH; Zhang XG
Cell Mol Immunol; 2008 Feb; 5(1):33-9. PubMed ID: 18318992
[TBL] [Abstract][Full Text] [Related]
12. PD-L1 gene polymorphisms and low serum level of PD-L1 protein are associated to type 1 diabetes in Chile.
Pizarro C; García-Díaz DF; Codner E; Salas-Pérez F; Carrasco E; Pérez-Bravo F
Diabetes Metab Res Rev; 2014 Nov; 30(8):761-6. PubMed ID: 24816853
[TBL] [Abstract][Full Text] [Related]
13. PD-1/PD-L1 expression on CD(4+) T cells and myeloid DCs correlates with the immune pathogenesis of atrial fibrillation.
Liu L; Zheng Q; Lee J; Ma Z; Zhu Q; Wang Z
J Cell Mol Med; 2015 Jun; 19(6):1223-33. PubMed ID: 25810125
[TBL] [Abstract][Full Text] [Related]
14. Patterns of PD-1, PD-L1, and PD-L2 expression in pediatric solid tumors.
Pinto N; Park JR; Murphy E; Yearley J; McClanahan T; Annamalai L; Hawkins DS; Rudzinski ER
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28488345
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stem Cells Upregulate the Expression of PD-L1 But Not VDR in Dendritic Cells.
Moravej A; Karimi MH; Geramizadeh B; Azarpira N; Zarnani AH; Yaghobi R; Khosravi M; Kalani M; Gharesi-Fard B
Immunol Invest; 2017 Jan; 46(1):80-96. PubMed ID: 27736253
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological analysis of PD-L1 and PD-L2 expression in pulmonary squamous cell carcinoma: Comparison with tumor-infiltrating T cells and the status of oncogenic drivers.
Kim MY; Koh J; Kim S; Go H; Jeon YK; Chung DH
Lung Cancer; 2015 Apr; 88(1):24-33. PubMed ID: 25662388
[TBL] [Abstract][Full Text] [Related]
17. PD-L1 expression in small cell neuroendocrine carcinomas.
Schultheis AM; Scheel AH; Ozretić L; George J; Thomas RK; Hagemann T; Zander T; Wolf J; Buettner R
Eur J Cancer; 2015 Feb; 51(3):421-6. PubMed ID: 25582496
[TBL] [Abstract][Full Text] [Related]
18. DCs sensitized with mPD-L1-Ig fusion protein improve the effect of heart transplantation in mice by promoting the generation of T-reg cells.
Liu C; Chen H; Jia J; Hong T; Wang C
Cell Immunol; 2014 Jul; 290(1):169-77. PubMed ID: 24997656
[TBL] [Abstract][Full Text] [Related]
19. Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation.
Kuipers H; Muskens F; Willart M; Hijdra D; van Assema FB; Coyle AJ; Hoogsteden HC; Lambrecht BN
Eur J Immunol; 2006 Sep; 36(9):2472-82. PubMed ID: 16917960
[TBL] [Abstract][Full Text] [Related]
20. Efficient nontoxic delivery of PD-L1 and PD-L2 siRNA into dendritic cell vaccines using the cationic lipid SAINT-18.
Roeven MW; Hobo W; van der Voort R; Fredrix H; Norde WJ; Teijgeler K; Ruiters MH; Schaap N; Dolstra H
J Immunother; 2015 May; 38(4):145-54. PubMed ID: 25839440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
